Tech Company Financing Transactions
Mezzion Pharma Funding Round
Mezzion Pharma, operating out of Deerfield, secured $40 million from BRV Capital Management.
Transaction Overview
Company Name
Announced On
4/25/2023
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Undisclosed
Investors
BRV Capital Management (Lead Investor)
Proceeds Purpose
The company intends to use the capital to fund FUEL-2, their confirmatory phase 3 clinical trial, along with future commercialization and regulatory submissions in other countries including Europe.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
520 Lake Cook Rd 250
Deerfield, IL 60015
USA
Deerfield, IL 60015
USA
Phone
Website
Email Address
Overview
Mezzion Pharmaceuticals continuously strives to discover, develop and deliver new hope in areas of medicine where there was none before. With our extensive experience in drug development and clinical trials, and our strong conviction and compassion for everything we do, we know that our vision of a future where no patient with a rare disease is without hope is firmly within our grasp.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Park Dong
Chief Information Officer
Michael Vaia
Browse more venture capital transactions:
Prev: 4/25/2023: Seatfrog venture capital transaction
Next: 4/25/2023: Libraro venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs